These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 11681651

  • 1. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
    Richards J, Hirst P, Pitcairn G, Mahashabde S, Abramowitz W, Nolting A, Newman SP.
    J Aerosol Med; 2001; 14(2):197-208. PubMed ID: 11681651
    [Abstract] [Full Text] [Related]

  • 2. Single-dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide.
    Nolting A, Sista S, Abramowitz W.
    J Pharm Sci; 2002 Feb; 91(2):424-32. PubMed ID: 11835202
    [Abstract] [Full Text] [Related]

  • 3. Flunisolide HFA vs flunisolide CFC: pharmacokinetic comparison in healthy volunteers.
    Nolting A, Sista S, Abramowitz W.
    Biopharm Drug Dispos; 2001 Dec; 22(9):373-82. PubMed ID: 11870676
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide delivered by pressurized metered dose inhaler.
    Hirst PH, Pitcairn GR, Richards JC, Rohatagi S, Gillen MS, Newman SP.
    J Aerosol Med; 2001 Dec; 14(2):155-65. PubMed ID: 11681648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.
    Corren J, Tashkin DP.
    Clin Ther; 2003 Mar; 25(3):776-98. PubMed ID: 12852702
    [Abstract] [Full Text] [Related]

  • 8. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
    Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ.
    Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
    Ayres JG, Millar AB, Sykes AP.
    Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
    [Abstract] [Full Text] [Related]

  • 10. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
    Leach CL, Colice GL.
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
    [Abstract] [Full Text] [Related]

  • 11. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
    Cripps A, Riebe M, Schulze M, Woodhouse R.
    Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
    [Abstract] [Full Text] [Related]

  • 12. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients.
    Corren J, Nelson H, Greos LS, Bensch G, Goldstein M, Wu J, Wang S, Newman K.
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):405-11. PubMed ID: 11730183
    [Abstract] [Full Text] [Related]

  • 13. Comparison of beclomethasone dipropionate delivery by easyhaler dry powder inhaler and pMDI plus large volume spacer.
    Newman SP, Pitcairn GR, Adkin DA, Vidgren MT, Silvasti M.
    J Aerosol Med; 2001 Nov; 14(2):217-25. PubMed ID: 11681653
    [Abstract] [Full Text] [Related]

  • 14. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
    Houghton CM, Langley SJ, Singh SD, Holden J, Monici Preti AP, Acerbi D, Poli G, Woodcock A.
    Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
    [Abstract] [Full Text] [Related]

  • 15. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS, Middle M, Savic J, Perri VL, Herdman MJ.
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
    Perruchoud AP, Lundback B, Yigla M, Sykes AP.
    Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684
    [Abstract] [Full Text] [Related]

  • 18. Flunisolide HFA.
    Waugh J, Goa KL.
    Am J Respir Med; 2002 Jun; 1(5):369-72; discussion 373. PubMed ID: 14720039
    [Abstract] [Full Text] [Related]

  • 19. Factors affecting the efficiency of aerosol therapy with pressurised metered-dose inhalers through plastic spacers.
    Chuffart AA, Sennhauser FH, Wildhaber JH, Swiss Paediatric Respiratory Physiology Research Group.
    Swiss Med Wkly; 2001 Jan 12; 131(1-2):14-8. PubMed ID: 11205181
    [Abstract] [Full Text] [Related]

  • 20. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD, Walters EG.
    Clin Ther; 2011 Aug 12; 33(8):1069-76. PubMed ID: 21784529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.